Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry-Reference-Cited by-同舟云学术

Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

Published:2017-10-31 Issue:9 Volume:20 Page:1435-1441
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Esteve-Pastor María Asunción¹,Rivera-Caravaca José Miguel²,Roldán-Rabadán Inmaculada³,Roldán Vanessa²,Muñiz Javier⁴,Raña-Míguez Paula⁵,Ruiz-Ortiz Martín⁶,Cequier Ángel⁷,Bertomeu-Martínez Vicente⁸,Badimón Lina⁹,Anguita Manuel⁶,. Lip Gregory Y H¹⁰,Marín Francisco¹,

Affiliation:

1. Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBER-CV, Murcia, Spain

2. Department of Hematology and Clinical Oncology, Hospital Universitario Morales Meseguer, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain

3. Department of Cardiology, Hospital La Paz, Madrid, Spain, Madrid

4. Universidade da Coruña, Instituto Universitario de Ciencias de la Salud, Instituto de Investigación Biomédica de A Coruña (INIBIC), La Coruña, Spain

5. ODDS, SL, A Coruña, Spain

6. Department of Cardiology, Hospital Universitario Reina Sofía, Córdoba, Spain

7. Department of Cardiology, Hospital de Bellvitge, CIBER-CV, Barcelona, Spain

8. Department of Cardiology, Hospital Universitario de San Juan, Alicante, Spain

9. Cardiovascular Research Center (CSIC-ICCC), Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain

10. Institute of Cardiovascular Sciences, University of Birmingham, UK

Funder

Instituto de Salud Carlos III

ISCIII

Fundación Séneca

Instituto Murciano de Investigación Biosanitaria

Sociedad Española de Trombosis y Hemostasia